Similar articles for PMID: 25048011

Year	Number of Results
1892	2
1982	1
1993	1
1994	1
1995	1
1996	3
1998	1
1999	4
2000	1
2001	2
2002	3
2003	3
2004	6
2005	7
2006	5
2007	5
2008	7
2009	8
2010	7
2011	8
2012	6
2013	7
2014	7
2015	5
2016	3
2017	5
2018	4
2019	4
2020	2
2021	4
2022	6
2023	3
2024	0

1

Strontium potently inhibits mineralisation in bone-forming primary rat osteoblast cultures and reduces numbers of osteoclasts in mouse marrow cultures.

Wornham DP, Hajjawi MO, Orriss IR, Arnett TR. Wornham DP, et al. Osteoporos Int. 2014 Oct;25(10):2477-84. doi: 10.1007/s00198-014-2791-5. Epub 2014 Jul 22. Osteoporos Int. 2014. PMID: 25048011 Free PMC article.

2

Strontium ranelate in osteoporosis.

Reginster JY. Reginster JY. Curr Pharm Des. 2002;8(21):1907-16. doi: 10.2174/1381612023393639. Curr Pharm Des. 2002. PMID: 12171530 Review.

3

Osteoblasts play key roles in the mechanisms of action of strontium ranelate.

Brennan TC, Rybchyn MS, Green W, Atwa S, Conigrave AD, Mason RS. Brennan TC, et al. Br J Pharmacol. 2009 Aug;157(7):1291-300. doi: 10.1111/j.1476-5381.2009.00305.x. Epub 2009 Jun 25. Br J Pharmacol. 2009. PMID: 19563530 Free PMC article.

4

Dose-dependent effects of strontium on osteoblast function and mineralization.

Verberckmoes SC, De Broe ME, D'Haese PC. Verberckmoes SC, et al. Kidney Int. 2003 Aug;64(2):534-43. doi: 10.1046/j.1523-1755.2003.00123.x. Kidney Int. 2003. PMID: 12846748 Free article.

5

Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response.

Atkins GJ, Welldon KJ, Halbout P, Findlay DM. Atkins GJ, et al. Osteoporos Int. 2009 Apr;20(4):653-64. doi: 10.1007/s00198-008-0728-6. Epub 2008 Sep 2. Osteoporos Int. 2009. PMID: 18763010

6

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T. Udagawa N, et al. Bone. 1999 Nov;25(5):517-23. doi: 10.1016/s8756-3282(99)00210-0. Bone. 1999. PMID: 10574571

7

Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins.

Choudhary S, Halbout P, Alander C, Raisz L, Pilbeam C. Choudhary S, et al. J Bone Miner Res. 2007 Jul;22(7):1002-10. doi: 10.1359/jbmr.070321. J Bone Miner Res. 2007. PMID: 17371157 Free article.

8

Strontium ranelate increases the formation of bone-like mineralized nodules in osteoblast cell cultures and leads to Sr incorporation into the intact nodules.

Querido W, Farina M. Querido W, et al. Cell Tissue Res. 2013 Nov;354(2):573-80. doi: 10.1007/s00441-013-1669-8. Epub 2013 Jun 18. Cell Tissue Res. 2013. PMID: 23774883

9

Inhibition of osteoblast function in vitro by aminobisphosphonates.

Orriss IR, Key ML, Colston KW, Arnett TR. Orriss IR, et al. J Cell Biochem. 2009 Jan 1;106(1):109-18. doi: 10.1002/jcb.21983. J Cell Biochem. 2009. PMID: 19003973

10

Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells.

Barbara A, Delannoy P, Denis BG, Marie PJ. Barbara A, et al. Metabolism. 2004 Apr;53(4):532-7. doi: 10.1016/j.metabol.2003.10.022. Metabolism. 2004. PMID: 15045704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year